ovarian cancer awareness in the uk, page-18

Good question mikepike.
Lets have a look

100k units = $7m net profit
200k units = $14m net profit
300k units = $21m net profit
400k units = $28m net profit
500k units = $35m net profit
600k units = $42m net profit
700k units = $49m net profit

When you consider that OvPlex is a "superior" product on the market, I'd say conervatively that 300k tests per year is a minimum long term target.

When you consider it was awarded Biospectrum Asia product of the year and having just read that announcement, I came across something rather ineteresting..."with Singapore and INDIA to have access to the Diagnostic by the end of the year".

So we're in talks with CHINA and INDIA. These 2 markets would absolutely dwarf the UK and there is nothy wrong with the UK potential alone.

Just when I think I understand how big this could be, it gets better